This webinar is intended exclusively for healthcare professionals practicing in countries where the every-4-weeks (E4W) dosing regimen for pegunigalsidase alfa has been approved

By clicking "OK", I declare that I am a healthcare professional practicing in a country where the every-4-weeks (E4W) dosing regimen for pegunigalsidase alfa is approved and that I am eligible to access the content of this webinar.

Ok